Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02058420Phase 2Completed
Phase 2, randomised trial in osteoporosis (3 arms), sponsored by Texas Tech University Health Sciences Center. Primary endpoint: Serum Bone Resorption Marker at 12 weeks. Started Feb 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02058420.